ID   RUFY3_RAT               Reviewed;         469 AA.
AC   Q5FVJ0; A5HLX7; A5JUR6;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   29-MAY-2024, entry version 115.
DE   RecName: Full=Protein RUFY3 {ECO:0000305};
DE   AltName: Full=RUN and FYVE domain-containing protein 3 {ECO:0000312|RGD:1565242};
DE   AltName: Full=Rap2-interacting protein x {ECO:0000250|UniProtKB:Q9D394};
DE            Short=RIPx {ECO:0000250|UniProtKB:Q9D394};
DE   AltName: Full=Single axon-regulated protein {ECO:0000303|PubMed:17439943};
DE            Short=Singar {ECO:0000303|PubMed:17439943};
GN   Name=Rufy3 {ECO:0000312|RGD:1565242};
GN   Synonyms=Ripx {ECO:0000250|UniProtKB:Q9D394};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 82-92;
RP   139-151; 265-284; 306-328; 348-356 AND 403-411, FUNCTION, SUBCELLULAR
RP   LOCATION, PHOSPHORYLATION (ISOFORM 1), TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, INTERACTION WITH PIK3CA AND PIK3R1, INDUCTION, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=17439943; DOI=10.1074/jbc.m700770200;
RA   Mori T., Wada T., Suzuki T., Kubota Y., Inagaki N.;
RT   "Singar1, a novel RUN domain-containing protein, suppresses formation of
RT   surplus axons for neuronal polarity.";
RL   J. Biol. Chem. 282:19884-19893(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-5; THR-12; SER-49 AND THR-51,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Plays a role in the generation of neuronal polarity formation
CC       and axon growth (PubMed:17439943). Implicated in the formation of a
CC       single axon by developing neurons (PubMed:17439943). May inhibit the
CC       formation of additional axons by inhibition of PI3K in minor neuronal
CC       processes (PubMed:17439943). Plays a role in the formation of F-actin-
CC       enriched protrusive structures at the cell periphery (By similarity).
CC       Plays a role in cytoskeletal organization by regulating the subcellular
CC       localization of FSCN1 and DBN1 at axonal growth cones (By similarity).
CC       Promotes gastric cancer cell migration and invasion in a PAK1-dependent
CC       manner (By similarity). {ECO:0000250|UniProtKB:Q7L099,
CC       ECO:0000250|UniProtKB:Q9D394, ECO:0000269|PubMed:17439943}.
CC   -!- SUBUNIT: Interacts with PIK3CA and PIK3R1 (PubMed:17439943). Interacts
CC       with PAK1 (By similarity). Interacts (via C-terminus) with Ras-related
CC       Rab-5 proteins (By similarity). Interacts (via C-terminus) with Ras-
CC       related Rap-2 proteins (By similarity). Interacts (via N-terminus) with
CC       FSCN1; this interaction induces neuron axon development (By
CC       similarity). Interacts with DBN1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q7L099, ECO:0000250|UniProtKB:Q9D394,
CC       ECO:0000269|PubMed:17439943}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q7L099}.
CC       Endomembrane system {ECO:0000250|UniProtKB:Q7L099}. Cell projection,
CC       invadopodium {ECO:0000250|UniProtKB:Q7L099}. Perikaryon
CC       {ECO:0000269|PubMed:17439943}. Cell projection
CC       {ECO:0000269|PubMed:17439943}. Cell projection, growth cone
CC       {ECO:0000250|UniProtKB:Q9D394}. Cell projection, filopodium
CC       {ECO:0000250|UniProtKB:Q9D394}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q9D394}. Note=Localized in F-actin-enriched
CC       filopodia and lamellipodia at axonal growth cones (PubMed:17439943).
CC       Colocalizes with PAK1, F-actin, myosins and integrins in invadopodia at
CC       the cell periphery (By similarity). Colocalized with Ras-related Rab-5
CC       proteins in cytoplasmic vesicles (By similarity). Accumulates in axon
CC       growth cones in a F-actin-dependent manner (By similarity). Colocalized
CC       with FSCN1 and F-actin at filipodia and lamellipodia of axonal growth
CC       cones (By similarity). Colocalized with DBN1 and F-actin at
CC       transitional domain of the axonal growth cone (By similarity).
CC       {ECO:0000250|UniProtKB:Q7L099, ECO:0000250|UniProtKB:Q9D394,
CC       ECO:0000269|PubMed:17439943}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Singar1 {ECO:0000303|PubMed:17439943};
CC         IsoId=Q5FVJ0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Singar2 {ECO:0000303|PubMed:17439943};
CC         IsoId=Q5FVJ0-2; Sequence=VSP_026950;
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level)
CC       (PubMed:17439943). {ECO:0000269|PubMed:17439943}.
CC   -!- DEVELOPMENTAL STAGE: Low level expression in brain up to 15 dpc, higher
CC       level expression from 18 dpc to P14 with highest level around P4
CC       (PubMed:17439943). Low level expression in adult brain
CC       (PubMed:17439943). Low level expression in hippocampal neurons up to
CC       stage 2 in culture (PubMed:17439943). Higher level from stage 3 with
CC       highest level of isoform 1 on day 7 in vitro (DIV7) (PubMed:17439943).
CC       Phosphorylated isoform 1 from DIV7 with high level up to DIV28, isoform
CC       2 detectable from stage 3 to DIV7 (PubMed:17439943).
CC       {ECO:0000269|PubMed:17439943}.
CC   -!- INDUCTION: Up-regulated during neuronal polarization (PubMed:17439943).
CC       {ECO:0000269|PubMed:17439943}.
CC   -!- PTM: Isoform 1 is partially phosphorylated (PubMed:17439943).
CC       Phosphorylated by PAK1 (By similarity). {ECO:0000250|UniProtKB:Q7L099,
CC       ECO:0000269|PubMed:17439943}.
CC   -!- MISCELLANEOUS: Hippocampal neurons with reduced levels of RUFY3 show an
CC       increase in formation of additional axons (PubMed:17439943). This
CC       effect is suppressed in the presence of the PI3K inhibitor LY294002 and
CC       enhanced by overexpression of SHTN1 (PubMed:17439943). Overexpression
CC       of RUFY3 suppresses additional axons formed upon overexpression of
CC       SHTN1 (PubMed:17439943). {ECO:0000269|PubMed:17439943}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF538802; ABP99060.1; -; mRNA.
DR   EMBL; EF577045; ABQ45403.1; -; mRNA.
DR   EMBL; BC089952; AAH89952.1; -; mRNA.
DR   RefSeq; NP_001020298.1; NM_001025127.1. [Q5FVJ0-1]
DR   RefSeq; XP_008768270.1; XM_008770048.2.
DR   AlphaFoldDB; Q5FVJ0; -.
DR   SMR; Q5FVJ0; -.
DR   BioGRID; 262306; 2.
DR   STRING; 10116.ENSRNOP00000073742; -.
DR   GlyGen; Q5FVJ0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5FVJ0; -.
DR   PhosphoSitePlus; Q5FVJ0; -.
DR   PaxDb; 10116-ENSRNOP00000020608; -.
DR   ABCD; Q5FVJ0; 3 sequenced antibodies.
DR   GeneID; 360921; -.
DR   KEGG; rno:360921; -.
DR   UCSC; RGD:1565242; rat. [Q5FVJ0-1]
DR   AGR; RGD:1565242; -.
DR   CTD; 22902; -.
DR   RGD; 1565242; Rufy3.
DR   VEuPathDB; HostDB:ENSRNOG00000003428; -.
DR   eggNOG; KOG4381; Eukaryota.
DR   HOGENOM; CLU_014576_0_0_1; -.
DR   InParanoid; Q5FVJ0; -.
DR   OrthoDB; 5385125at2759; -.
DR   PRO; PR:Q5FVJ0; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000003428; Expressed in cerebellum and 20 other cell types or tissues.
DR   ExpressionAtlas; Q5FVJ0; baseline and differential.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0030175; C:filopodium; IDA:HGNC-UCL.
DR   GO; GO:0030426; C:growth cone; IDA:HGNC-UCL.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0007015; P:actin filament organization; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; IDA:HGNC-UCL.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISO:RGD.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB.
DR   CDD; cd17696; RUN_RUFY3; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.58.900; -; 1.
DR   InterPro; IPR047335; RUFY1-3.
DR   InterPro; IPR004012; Run_dom.
DR   InterPro; IPR037213; Run_dom_sf.
DR   InterPro; IPR047334; RUN_RUFY3.
DR   PANTHER; PTHR45956:SF1; PROTEIN RUFY3; 1.
DR   PANTHER; PTHR45956; RUN AND FYVE DOMAIN-CONTAINING PROTEIN 2-LIKE PROTEIN; 1.
DR   Pfam; PF02759; RUN; 1.
DR   SMART; SM00593; RUN; 1.
DR   SUPFAM; SSF140741; RUN domain-like; 1.
DR   PROSITE; PS50826; RUN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell projection; Coiled coil;
KW   Cytoplasm; Developmental protein; Differentiation;
KW   Direct protein sequencing; Membrane; Neurogenesis; Oncogene;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..469
FT                   /note="Protein RUFY3"
FT                   /id="PRO_0000245836"
FT   DOMAIN          95..227
FT                   /note="RUN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00178"
FT   COILED          267..464
FT                   /evidence="ECO:0000255"
FT   MOD_RES         5
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         12
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D394"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         51
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         60
FT                   /note="D -> DSWEDLTDLVEQVRADPED (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17439943"
FT                   /id="VSP_026950"
SQ   SEQUENCE   469 AA;  52907 MW;  98580BE52F52BC04 CRC64;
     MSALTPPTDM PTPTTDKITQ AAMETIYLCK FRVSMDGEWL CLRELDDISL TPDPEPTHED
     PNYLMANERM NLMNMAKLSI KGLIESALNL GRTLDSDYAP LQQFFVVMEH CLKHGLKAKK
     TFLGQNKSFW GPLELVEKLV PEAAEITASV KDLPGLKTPV GRGRAWLRLA LMQKKLSEYM
     KALINKKELL SEFYEANALM MEEEGAIIAG LLVGLNVIDA NFCMKGEDLD SQVGVIDFSM
     YLKDGNSSKG SEGDGQITAI LDQKNYVEEL NRHLNATVNN LQAKVDALEK SNTKLTEELA
     VANNRIITLQ EEMERVKEES SYLLESNRKG PKQDRTAEGQ ALSEARKHLK EETQLRLDVE
     KELELQISMR QEMELAMKML EKDVCEKQDA LVSLRQQLDD LRALKHELAF KLQSSDLGVK
     QKSELNSRLE EKTNQMAATI KQLEQSEKDL VKQAKTLNSA ANKLIPKHH
//
